Axsome Therapeutics (AXSM) Reports Q4 Loss, Tops Revenue Estimates

Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of$ 1.21. This compares to loss of $1.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 39.67%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1.24 per share when it actually produced a loss of $1.32, delivering a surprise of -6.45%.Over the last four quarters, th ...